Phase 4 COPD Trial, Recruiting (NCT06892210)

Phase 4 COPD Trial, Recruiting NCT06892210 Sponsor: Copenhagen Respiratory Research Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06892210 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 40 years old or older
You have been diagnosed with a flare-up (sudden worsening) of chronic obstructive pulmonary disease (COPD), recorded under the medical code ICDJ44

Who may not be able to join:

You have a condition that requires treatment with a specific type of steroid medication (confirm with trial site)
You are currently pregnant or breastfeeding
You currently have active tuberculosis (TB) or a serious invasive fungal infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Jens-Ulrik Stæhr Jensen, MD, PHD, COP:RESP

Phone: 38673057

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06892210

Sponsor: Copenhagen Respiratory Research

Phase: Phase 4

Status: Recruiting

Condition: COPD

Trial contact: 38673057

More information: https://clinicaltrials.gov/study/NCT06892210

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 40 years old or older
You have been diagnosed with a flare-up (sudden worsening) of chronic obstructive pulmonary disease (COPD), recorded under the medical code ICDJ44

Who may not be able to join:

You have a condition that requires treatment with a specific type of steroid medication (confirm with trial site)
You are currently pregnant or breastfeeding
You currently have active tuberculosis (TB) or a serious invasive fungal infection

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Copenhagen Respiratory Research

Registry

ClinicalTrials.gov

Start date

10 March 2026

Est. completion

1 August 2030

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Readmission for COPD exacerbation or death from all causes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov